BioStem TechnologiesBSEM -5.17%49 Days Inventory is 172.53 as of Sep. 2025, which is 16% above its 10-year median of 149.05. GuruFocus rates BSEM with a GF Score™ of 49/100 and a GF Value™ of $139.96 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 638 Biotechnology companies, BioStem Technologies ranks better than 53.76% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
BioStem Technologies's Inventory Turnover for the
three
months ended in Sep. 2025 was 0.53.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BioStem Technologies's Inventory-to-Revenue for the
three
months ended in Sep. 2025 was 0.22.
BioStem Technologies (OTCPK:BSEM) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
BioStem Technologies's Inventory Turnover for the
three
months ended in Sep. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BioStem Technologies's Inventory to Revenue for the
three
months ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
BioStem Technologies Days Inventory Related Terms
BioStem Technologies Days Inventory Historical Data
* Premium members only.
The historical data trend for BioStem Technologies's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSEM vs XLO, TCRX, MNOV: Days Inventory Comparison
For the Biotechnology subindustry, BioStem Technologies's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioStem Technologies Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BioStem Technologies's Days Inventory distribution charts can be found below:
* The bar in red indicates where BioStem Technologies's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioStem Technologies (BSEM) has a Days Inventory of 172.53 as of Sep. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on BioStem Technologies and its competitors. This is 16% above median its historical median of 149.05. Over the past decade, BioStem Technologies' Days Inventory has ranged from 32.97 to 1,198.51. According to the industry distribution chart, BioStem Technologies ranks #295 out of 638 companies in the Biotechnology industry, placing it in the top 46.2%.
Is BioStem Technologies' Days Inventory too high?
BioStem Technologies' current Days Inventory of 172.53 is 16% above median its 10-year median of 149.05. Over the past 10 years, this metric has ranged from a low of 32.97 to a high of 1,198.51. The Biotechnology industry median Days Inventory is 183.88. BioStem Technologies' value of 172.53 is 6.2% below this industry median. Based on the distribution chart, BioStem Technologies ranks #295 out of 638 companies in the Biotechnology industry, which is above the industry midpoint. Overall, BioStem Technologies has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BioStem Technologies' Days Inventory compare to XLO and TCRX?
According to the Biotechnology industry distribution chart, BioStem Technologies ranks #295 out of 638 companies for Days Inventory. This puts BioStem Technologies in the upper half of its industry. The industry median Days Inventory is 183.88. BioStem Technologies' value of 172.53 is 6.2% below this benchmark. Historically, BioStem Technologies' own Days Inventory has ranged from 32.97 to 1,198.51 over the past decade. While the company's 10-year median is 149.05 vs. the industry median of 183.88, BioStem Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.88, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BioStem Technologies's current Days Inventory of 172.53 is 6.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on BioStem Technologies and its competitors. For the Biotechnology industry, the median Days Inventory is 183.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioStem Technologies's current Days Inventory is 172.53, which is 16% above median its own 10-year median of 149.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioStem Technologies stock overvalued right now?
Based on GuruFocus' analysis, BioStem Technologies (BSEM) is currently considered Possible Value Trap. The stock's GF Value™ is $139.96, compared to a current price of $3.30 — trading 97.6% below its estimated fair value. The current Days Inventory is 172.53, which is 16% above median its 10-year median of 149.05 and 6.2% below the Biotechnology industry median of 183.88. BioStem Technologies' overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For BioStem Technologies (BSEM), the current Days Inventory is 172.53 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BioStem Technologies (BSEM) Overvalued in 2026?
Based on GuruFocus' analysis, BioStem Technologies stock appears to be undervalued.
The current stock price of $3.30 is trading 97.6% below its estimated GF Value™ of $139.96.
GuruFocus considers BioStem Technologies to be Possible Value Trap.
Key valuation signals for BSEM:
Days Inventory: 172.53 (16% above median its 10-year median of 149.05)
GF Value™: $139.96 vs. price of $3.30 (97.6% below fair value)
Industry Position: 6.2% below the Biotechnology median (#295 of 638)
No single metric tells the full story. See the BSEM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.
49GF Score
Get the complete analysis for BSEM
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSEM has been successfully added to your 
